About Remmie Health
Remmie Health manufactures FDA-registered, portable digital otoscopes designed for home and telehealth-enabled ear, nose, and throat (ENT) examination and remote sharing with healthcare providers. The company's core product line includes the Remmie 3 and Remmie 4, intelligent otoscope cameras with high-definition (720p) imaging, wireless connectivity, real-time video streaming capabilities, and cloud-enabled mobile applications for iOS and Android devices. Remmie devices feature 3.9mm diameter lenses, adjustable brightness (5 levels), waterproof design, 2.4GHz Wi-Fi connectivity, and battery life supporting extended use. All devices ship with disposable specula, cleaning pads, charging accessories, and setup guidance. The Remmie App provides AI-guided image capture, local recording and saving of images and video, and live streaming to clinicians for remote diagnosis and intervention without requiring an internet connection for basic operation. The company targets parents, caregivers, and patients managing common ear and upper respiratory conditions (otitis media, otitis externa, sinusitis, pharyngitis, tonsillitis, strep throat, pink eye) while reducing costly emergency room and urgent care visits. Remmie devices are FDA Class 1 registered, CE marked, and cleared by Health Canada and Australian TGA. The company explicitly clarifies that Remmie devices are examination tools only and does not provide diagnostic, prescription, or telehealth services; users must consult independent healthcare providers for clinical care. Regulatory compliance and clinical validation are central to the company's positioning.